A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
Proximity ligation assay is a very useful technique to localize and quantify arginine methylation of a given protein when the modified arginine residue is unknown and/or if no specific antibody is available.
Arginine methylation is emerging as a key post-translational modification involved in a large range of biological processes. Its study in tissue is often limited by the lack of a specific antibody recognizing the target arginine residue. Proximity ligation assay (PLA) was originally developed to study protein/protein interactions. Here, we describe in detail a PLA protocol dedicated to the detection of arginine methylation that we applied to the glucocorticoid receptor (GR). Having previously shown that PRMT5 dimethylates GRs in cells, we used PLA with a pan symmetrical dimethyl antibody and an anti-GR antibody to measure GR methylation in breast tumors. We demonstrate that PLA offers a unique approach to measure arginine methylation of a target protein, even when the site of methylation has not been identified. This technique could be extended to other post-translational modifications where effective pan antibodies are available. Hence, we detail the PLA technology used to detect arginine methylation in fixed tissue using GR as an example.
Arginine methylation by protein arginine methyltransferases (PRMTs) is an abundant post-translational modification (PTM) involved in numerous biological processes. PRMTs catalyze the transfer of methyl groups from the S-adenosyl methionine to arginine residues. The PRMT family comprises nine members classified according to the type of methylation they perform. All members perform monomethylation (MMA). Type 1 (PRMT1, 2, 3, 4, 6, and 8) PRMTs catalyze asymmetrical dimethylation (ADMA), whereas type 2 (PRMT5 and 9) catalyze symmetrical dimethylation (SDMA), and type 3 (PRMT7) only generate MMA1. By methylating numerous substrates, the different P....
Written informed consent was obtained from each patient. The study protocol was approved by the institutional ethics committee of the Cancer Research Center of Lyon.
1. Choice of the antibodies
Using the procedure described above, it is possible to detect and quantify the methylation of a protein of interest. Here, we show the example of the methylation of GR by PRMT5. The antibodies and the experimental conditions for PLA were previously applied to cells10. Briefly, primary antibodies targeting GR and SDMA are recognized by proximity probes conjugated with complementary oligonucleotides. Then, the hybridization of a circular DNA probe occurs when the proteins are in close proximity. Sub.......
Arginine methylation, like other PTMs, contributes to the fine regulation of protein functions. However, its impact is underestimated due to the difficulty in assessing these modifications, primarily because of a lack of tools. This is particularly true when studying methylation in vivo, where the only way to measure arginine methylation is to possess specific antibodies recognizing the methylated residue of the protein of interest. This clearly constitutes a limitation as the methylated arginine residue must be.......
We would like to thank B. Manship for proofreading the manuscript. We acknowledge Laura Francols, Clémentine Le Nevé, Research pathology platform (CRCL) for technical help. Figure 1 was created using Servier Medical Art. This study was supported by the Ligue Inter-régionale contre le Cancer and the Association: 'Le Cancer du sein, parlons-en.'
....Name | Company | Catalog Number | Comments |
Adhesion slides TOMO 90°, x100 | VWR | 631-1239 | |
anti-GR antibody (mouse) | Santa Cruz | sc393232 | |
anti-GR antibody (mouse) | santa cruz | sc393232 | |
anti-PRMT5 antibody (rabbit) | Merck | 07-405 | |
anti-SDMA antibody (rabbit) | CST | 13222 | |
Automate d'inclusion | Leica | ASP 6025 | Paraffin infiltration and block preparation |
Autostainer XL | Leica | ST5010 | Autostainer |
Cassettes Q path macrostar III x1500 | VWR | 720-2233 | |
CC1 | Roche | 5279801001 | |
Citrate Buffer pH 6 10x, 100 mL | MMF | F/T0050 | |
Dako antibody diluent | Dako Agilent | S202230-2 | antibody diluent |
Discovery ChromoMap Diaminobenzidine (DAB) kit | Roche | 760-159 | Diaminobenzidine (DAB) kit |
Discovery Wash | Roche | 7311079001 | |
Duolink insitu PLA probe anti-mouse minus | Sigma-Aldrich | DUO92004 | PLA kit (probe anti-rabbit minus) |
Duolink insitu detection reagents brightfield | Sigma-Aldrich | DUO92012 | PLA kit (in situ detection reagents) |
Duolink insitu PLA probe anti-rabbit plus | Sigma-Aldrich | DUO92002 | PLA kit (probe anti-rabbit plus) |
Duolink insitu wash buffer brightfield | Sigma-Aldrich | DUO82047 | PLA kit (in situ wash buffer) |
Ethanol 96% VOL TECHNISOLV, 5 L | VWR | 83804.360 | |
Ethanol absolute ≥99.8%, AnalaR NORMAPUR ACS, 5 L | VWR | 20821.365 | |
EZ Prep 10x | Roche | 5279771001 | |
Formol, ready to use, 5 L | MMF | F/40877-36 | Formalin |
Fully automated glass coverslipper | Leica | CV5030 | automated coverslipper |
Glass coverslips 24 x 40 | Dutscher | 100037 | |
Hematoxylin | Ventana | 760-2021 | |
IHC instrument | Roche | DISCOVERY XT | Automation of IHC |
LCS | Roche | 5264839001 | |
Microtome | Thermo Scientific | Microm HM340E | Cutting of the tissues including in blocks |
Mounting Medium Pertex | Histolab | 00801-FR | |
PAP Pen for immunostaining | Sigma-Aldrich | Z672548-1EA | |
Paraffin Wax tek III, 4 x 2, 5 kg | Sakura | 4511 | |
Pasteur Disposable Pipettes | Fisher Scientific | 12583237 | |
PBS Buffer 10x, 100 mL | MMF | F/T0020 | |
Reaction Buffer 10x | Roche | 5353955001 | |
Ribo Wash 10x | Roche | 5266262001 | |
RiboCC1 | Roche | 5266297001 | |
Secondary antibody anti-mouse | Abcam | ab133469 | |
Secondary antibody OmniMap anti-rabbit HRP | Roche | 760-4311 | |
Tissue Embedding center | MMF | EC 350 | |
Xylene (mixture of isomers) ≥98.5%, AnalaR NORMAPUR ACS, 5 L | VWR | 28975.360 | |
Zeiss Axio Imager M2 microscope | upright bright-field microscope |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved